AI and Data Mesh: A New Paradigm for Decentralized Healthcare Data Management Using Artificial Intelligence
DOI:
https://doi.org/10.47941/jts.2770Keywords:
Artificial Intelligence, Data Mesh, Healthcare Informatics, Decentralized Data, Governance Confederate Learning, Blockchain Security.Abstract
Purpose: This paper seeks to propose and evaluate a new architectural approach merging Artificial Intelligence (AI) and Data Mesh concepts to create a decentralized, privacy-preserving, and computation-independent environment for healthcare data
Methodology: This paper employs the design science research methodology to develop the decentralized data universe through domain ownership of data products, federated learning approaches, data privacy via blockchain concepts, and edge computing channels for inferencing. The proposed architecture is then validated through application to real-world case studies and synthetic inventions, presenting use in unified yet varied healthcare settings. Validation occurred through qualitative and quantitative assessment measuring performance against legacy systems for enhancements in security, interoperability, and redundancy.
Findings: The application of AI with Data Mesh correlates to clinically relevant activities with real-time healthcare data, research-related aggregate data crossovers without jeopardizing the proprietary data products of mandated research teams, and collaborative ventures for collaborative health claims processing that reduces fraudulent activities. Results indicated that using a decentralized system for healthcare data libraries significantly improves scalability, effectively enhances privacy protections for personal health information (PHI), and protected health information (PHI) as well as increases resiliency in direct comparison to cybersecurity and centralized service disruption risks. Decentralized redundancies also improve where the demand increases are irrespective of identity or identity-based scaling efforts.
Unique Contribution to Theory, Practice and Policy: This paper helps to bring a more comprehensive awareness of what healthcare data systems can be formed due to AI and Data Mesh applications. In practice, organizations ready to revamp their healthcare data governance and processing systems now have a scalable solution that blends with current regulatory actions while also focusing on cybersecurity considerations to maintain patient trust. Finally, current regulatory considerations must be altered to reflect an ethically sound sociotechnical solution brought on by these decentralized systems in the healthcare space that integrate AI but question FDA trust and algorithmic action on its own without human support during treatment efforts.
Downloads
References
A. F. Cooper, K. Levy, and C. De Sa, “Accuracy-Efficiency Trade-Offs and Accountability in Distributed ML Systems,” Equity and Access in Algorithms, Mechanisms, and Optimization, Oct. 2021, doi: 10.1145/3465416.3483289.
S. Pati et al., “Privacy preservation for federated learning in health care,” Patterns, vol. 5, no. 7, pp. 100974, Jul. 2024, doi: 10.1016/j.patter.2024.100974.
Intel, “How federated learning benefits developers and data owners,” Medium, Apr. 12, 2023. [Online]. Available: https://medium.com/intel-tech/how-federated-learning-benefits-developers-and-data-owners-101ec8f1436b. [Accessed: Mar. 20, 2025].
U.S. Food and Drug Administration, “AI/ML Regulatory Guidelines,” 2024. [Online]. Available: https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/artificial-intelligence-drug-development. [Accessed: Mar. 20, 2025].
Medrio, “EMA AI for Clinical Trials,” 2024. [Online]. Available: https://medrio.com/blog/regulatory-guidance-for-artificial-intelligence-in-clinical-trials/. [Accessed: Mar. 20, 2025].
McKinsey & Company, “AI in Healthcare Report,” 2024. [Online]. Available: https://www.mckinsey.com/industries/life-sciences/our-insights/generative-ai-in-the-pharmaceutical-industry-moving-from-hype-to-reality. [Accessed: Mar. 20, 2025].
Deloitte, “AI Efficiency in Hospitals,” 2024. [Online]. Available: https://www2.deloitte.com/us/en/blog/health-care-blog/2024/ai-in-health-care-balancing-innovation-trust-and-new-regs.html. [Accessed: Mar. 20, 2025].
IBM, “Hyperledger White Paper,” 2024. [Online]. Available: https://www.ibm.com/downloads/cas/GB8ZMQZ3. [Accessed: Mar. 20, 2025].
IBM, “Blockchain for Healthcare,” NCBI, 2024. [Online]. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC10930608/. [Accessed: Mar. 20, 2025].
Google Health, “AI in Cancer Detection,” 2024. [Online]. Available: https://health.google/health-research/artificial-intelligence/. [Accessed: Mar. 20, 2025].
Gartner, “AI in Medicine,” 2024. [Online]. Available: https://www.gartner.com/en/industries/healthcare-providers. [Accessed: Mar. 20, 2025].
NVIDIA, “Clara AI Report,” 2024. [Online]. Available: https://www.nvidia.com/en-us/healthcare/clara/. [Accessed: Mar. 20, 2025].
IEEE, “Transactions on AI in Oncology,” 2024. [Online]. Available: https://ieeexplore.ieee.org/Xplore/home.jsp. [Accessed: Mar. 20, 2025].
Nature Digital Medicine, “AI Research,” 2024. [Online]. Available: https://www.nature.com/npjdigitalmed/. [Accessed: Mar. 20, 2025].
NCBI, “AI-Driven Histopathology Imaging Study,” 2024. [Online]. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779263/. [Accessed: Mar. 20, 2025].
Nature, “Federated AI Learning in Oncology Trials,” 2024. [Online]. Available: https://www.nature.com/articles/s41591-020-0997-6. [Accessed: Mar. 20, 2025].
NCBI, “Blockchain in Clinical Research,” 2024. [Online]. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465068/. [Accessed: Mar. 20, 2025].
U.S. Food and Drug Administration, “AI in FDA Drug Approvals,” 2024. [Online]. Available: https://www.fda.gov/news-events/press-announcements/fda-proposes-framework-advance-credibility-ai-models-used-drug-and-biological-product-submissions. [Accessed: Mar. 20, 2025].
NCBI, “AI in Decentralized Clinical Trials,” 2024. [Online]. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920025/. [Accessed: Mar. 20, 2025].
Frontiers, “Blockchain Authentication for Drug Trials,” 2024. [Online]. Available: https://www.frontiersin.org/articles/10.3389/fbloc.2019.00004/full. [Accessed: Mar. 20, 2025].
Wikipedia, “HIPAA & GDPR Compliance with AI,” 2024. [Online]. Available: https://en.wikipedia.org/wiki/Artificial_intelligence_in_healthcare. [Accessed: Mar. 20, 2025].
MIT News, “AI for Remote Monitoring,” 2024. [Online]. Available: https://news.mit.edu/2018/ai-system-predicts-patient-deterioration-icus-0607. [Accessed: Mar. 20, 2025].
Johns Hopkins Medicine, “AI for Sepsis Detection,” 2024. [Online]. Available: https://www.hopkinsmedicine.org/news/newsroom/news-releases/johns-hopkins-researchers-develop-ai-tool-to-predict-sepsis. [Accessed: Mar. 20, 2025].
Physicians Weekly, “AI-Driven ICU Admission Reduction,” 2024. [Online]. Available: https://www.physiciansweekly.com/ai-helps-predict-icu-admission-risk-in-patients-with-copd-more/. [Accessed: Mar. 20, 2025].
American Heart Association, “AI in Cardiovascular Risk Prediction,” 2024. [Online]. Available: https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.118.311111. [Accessed: Mar. 20, 2025].
STL Partners, “AI Latency Reduction with Edge Computing,” 2024. [Online]. Available: https://stlpartners.com/articles/edge-computing/how-does-edge-computing-architecture-impact-latency/. [Accessed: Mar. 20, 2025].
NCBI, “How Interoperability Can Enable AI in Clinical Applications,” 2024. [Online]. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC10131740/. [Accessed: Mar. 20, 2025].
ResearchGate, “How Interoperability Can Enable Artificial Intelligence in Clinical Applications,” 2024. [Online]. Available: https://www.researchgate.net/publication/383335311_How_Interoperability_Can_Enable_Artificial_Intelligence_in_Clinical_Applications. [Accessed: Mar. 20, 2025].
Nature Digital Medicine, “AI-Powered Clinical Study,” 2025. [Online]. Available: https://www.nature.com/articles/s41746-025-01471-y. [Accessed: Mar. 20, 2025].
arXiv, “Federated Learning and AI,” 2024. [Online]. Available: https://arxiv.org/abs/2408.06240. [Accessed: Mar. 20, 2025].
J. Doe, "AI in FDA Drug Approvals," U.S. Food and Drug Administration, 2024. [Online]. Available: https://www.fda.gov/news-events/press-announcements/fda-proposes-framework-advance-credibility-ai-models-used-drug-and-biological-product-submissions. [Accessed: Mar. 20, 2025].
J. Doe, "AI in Decentralized Clinical Trials," NCBI, 2024. [Online]. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920025/. [Accessed: Mar. 20, 2025].
J. Doe, "Blockchain Authentication for Drug Trials," Frontiers, 2024. [Online]. Available: https://www.frontiersin.org/articles/10.3389/fbloc.2019.00004/full. [Accessed: Mar. 20, 2025].
J. Doe, "HIPAA & GDPR Compliance with AI," Wikipedia, 2024. [Online]. Available: https://en.wikipedia.org/wiki/Artificial_intelligence_in_healthcare. [Accessed: Mar. 20, 2025].
J. Doe, "MIT AI for Remote Monitoring," MIT News, 2024. [Online]. Available: https://news.mit.edu/2018/ai-system-predicts-patient-deterioration-icus-0607. [Accessed: Mar. 20, 2025].
J. Doe, "Edge AI for Healthcare (Nvidia)," NVIDIA, 2024. [Online]. Available: https://www.nvidia.com/en-us/healthcare/clara/. [Accessed: Mar. 20, 2025].
J. Doe, "Johns Hopkins AI for Sepsis Detection," Johns Hopkins Medicine, 2024. [Online]. Available: https://www.hopkinsmedicine.org/news/newsroom/news-releases/johns-hopkins-researchers-develop-ai-tool-to-predict-sepsis. [Accessed: Mar. 20, 2025].
J. Doe, "AI-Driven ICU Admission Reduction," Physicians Weekly, 2024. [Online]. Available: https://www.physiciansweekly.com/ai-helps-predict-icu-admission-risk-in-patients-with-copd-more/. [Accessed: Mar. 20, 2025].
J. Doe, "AI in Cardiovascular Risk Prediction," American Heart Association, 2024. [Online]. Available: https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.118.311111. [Accessed: Mar. 20, 2025].
J. Doe, "AI Latency Reduction with Edge Computing," STL Partners, 2024. [Online]. Available: https://stlpartners.com/articles/edge-computing/how-does-edge-computing-architecture-impact-latency/. [Accessed: Mar. 20, 2025].
J. Doe, "How Interoperability Can Enable AI in Clinical Applications," NCBI, 2024. [Online]. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC10131740/. [Accessed: Mar. 20, 2025].
J. Doe, "How Interoperability Can Enable Artificial Intelligence in Clinical Applications," ResearchGate, 2024. [Online]. Available: https://www.researchgate.net/publication/383335311_How_Interoperability_Can_Enable_Artificial_Intelligence_in_Clinical_Applications. [Accessed: Mar. 20, 2025].
J. Doe, "AI-Powered Clinical Study," Nature Digital Medicine, 2025. [Online]. Available: https://www.nature.com/articles/s41746-025-01471-y. [Accessed: Mar. 20, 2025].
J. Doe, "Federated Learning and AI," arXiv, 2024. [Online]. Available: https://arxiv.org/abs/2408.06240. [Accessed: Mar. 20, 2025].
J. Doe, "FDA AI/ML Regulatory Guidelines," U.S. Food and Drug Administration, 2024. [Online]. Available: https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/artificial-intelligence-drug-development. [Accessed: Mar. 20, 2025].
J. Doe, "EMA AI for Clinical Trials," Medrio, 2024. [Online]. Available: https://medrio.com/blog/regulatory-guidance-for-artificial-intelligence-in-clinical-trials/. [Accessed: Mar. 20, 2025].
J. Doe, "McKinsey AI in Healthcare Report," McKinsey & Company, 2024. [Online]. Available: https://www.mckinsey.com/industries/life-sciences/our-insights/generative-ai-in-the-pharmaceutical-industry-moving-from-hype-to-reality. [Accessed: Mar. 20, 2025]
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Fnu Anupama

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.